ImmunityBio, Inc. (NASDAQ:IBRX - Free Report) - Equities researchers at HC Wainwright lifted their FY2028 EPS estimates for ImmunityBio in a report released on Thursday, October 15th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings of $0.82 per share for the ye